Novartis Aktie
99,23CHF | -0,55CHF | -0,55% |
WKN: 904278 / ISIN: CH0012005267
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 105 794 | 104 323 | 101 703 | 76 057 | 75 883 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,43 | 0,45 | 0,47 | 0,54 | 0,58 |
Bilanz (in Mio. CHF) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 26 229 | 41 656 | 34 149 | 25 654 | 26 919 |
Summe Anlagevermögen | 90 619 | 82 155 | 78 508 | 61 729 | 69 835 |
Summe Aktiva | 116 848 | 123 811 | 112 657 | 87 383 | 96 754 |
Bilanz (in Mio. CHF) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 66 759 | 62 015 | 57 679 | 48 036 | 56 765 |
Summe Eigenkapital | 50 090 | 61 796 | 54 978 | 39 347 | 39 989 |
Summe Passiva | 116 848 | 123 811 | 112 657 | 87 383 | 96 754 |
Adresse
Lichtstrasse 35, 4056 Basel | |
Telefon | +41 (61) 324-11-11 |
Internet | http://www.novartis.com |
Management
Aharon Gal
Chief Strategy & Growth Officer |
Ana de Pro Gonzalo
Independent Non-Executive Director |
Bridgette P. Heller
Independent Non-Executive Director |
Charlotte Pamer-Wieser
Secretary |
Daniel Hochstrasser
Independent Non-Executive Director |
Elizabeth McNally
Director |
Frans van Houten
Independent Non-Executive Director |
Giovanni Caforio
Chairman |
Harry Werner Kirsch
Chief Financial Officer |
Ingrid Zhang
Chief Commercial Officer-International |
John D. Young
Independent Non-Executive Director |
Karen L. Hale
Chief Legal Officer |
Kees Roks
Chief Audit Officer |
Klaus Moosmayer
Chief Ethics, Risk & Compliance Officer |
Linda Kanitra
Associate Director-Drug Development |
Marco Gadola
Senior Auditor |
Maria Victoria Cuevas-Pautonnier
Director-Investor Relations & Head-ESG |
Mary Elizabeth Doherty
Independent Non-Executive Director |
Michelle Weese
Chief Corporate Affairs Officer |
Nancy C. Andrews
Independent Non-Executive Director |
Patrice Bula
Lead Independent Non-Executive Director |
Patrick Horber
President-International |
Robert Kowalski
Chief People & Organization Officer |
Samir Shah
Global Head-Investor Relations |
Shreeram Aradhye
Chief Medical Officer & President-Development |
Simon E. Moroney
Vice Chairman |
Steffen Lang
President-Operations |
Ton Büchner
Independent Non-Executive Director |
Vasant Narasimhan
Chief Executive Officer |